Alaunos Therapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Effective November 2, 2021, Ms. Heidi Hagen has resigned as member of the Board of Directors (“the Board”) of Ziopharm Oncology, Inc. (the “Company”).
Extracted from this filing and checked against the source text.
Heidi Hagen resigned as member of the Board of Directors at Alaunos Therapeutics, Inc..
Effective November 2, 2021, Ms. Heidi Hagen has resigned as member of the Board of Directors (“the Board”) of Ziopharm Oncology, Inc. (the “Company”).View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.